Connect with us

Technology

Pulse Oximetry Market size is set to grow by USD 1.18 billion from 2024-2028, Increasing prevalence of chronic respiratory diseases to boost the market growth, Technavio

Published

on

NEW YORK, July 19, 2024 /PRNewswire/ — The global pulse oximetry market  size is estimated to grow by USD 1.18 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 8.09%  during the forecast period.  Increasing prevalence of chronic respiratory diseases is driving market growth, with a trend towards increasing online marketing strategies by market vendors. However, limitations and complications associated with pulse oximeters  poses a challenge. Key market players include American Diagnostic Corp., Baxter International Inc., Contec Medical Systems Co. Ltd., Dragerwerk AG and Co. KGaA, General Electric Co., Halma Plc, Heal Force Biomeditech Holdings Ltd., ICU Medical Inc., Konica Minolta Inc., Koninklijke Philips N.V., Lepu Medical Technology Beijing Co. Ltd., Masimo Corp., Medical Information Technology Inc., Medtronic Plc, Nihon Kohden Corp., Nonin Medical Inc., OMRON Corp., SCHILLER AG, Shenzhen Mindray BioMedical Electronics Co. Ltd, and Vyaire Medical Inc..

Get a detailed analysis on regions, market segments, customer landscape, and companies – Click for the snapshot of this report

Forecast period

2024-2028

Base Year

2023

Historic Data

2017 – 2021

Segment Covered

Product (Bedside/desktop pulse oximeters, Handheld pulse oximeters, Fingertip pulse oximeters, and Wrist-worn pulse oximeters), End-user (Hospitals and clinics and Alternative care settings), and Geography (North America, Europe, Asia, and Rest of World (ROW))

Region Covered

North America, Europe, Asia, and Rest of World (ROW)

Key companies profiled

American Diagnostic Corp., Baxter International Inc., Contec Medical Systems Co. Ltd., Dragerwerk AG and Co. KGaA, General Electric Co., Halma Plc, Heal Force Biomeditech Holdings Ltd., ICU Medical Inc., Konica Minolta Inc., Koninklijke Philips N.V., Lepu Medical Technology Beijing Co. Ltd., Masimo Corp., Medical Information Technology Inc., Medtronic Plc, Nihon Kohden Corp., Nonin Medical Inc., OMRON Corp., SCHILLER AG, Shenzhen Mindray BioMedical Electronics Co. Ltd, and Vyaire Medical Inc.

Key Market Trends Fueling Growth

In response to the growing trend of using pulse oximeters in home healthcare settings, market vendors have shifted their focus towards online marketing strategies to boost sales. Companies such as Masimo, Nonin Medical, CONTEC MEDICAL SYSTEms, OMRON, Santa Medical, and iHealth Labs are expanding their online presence through social media and e-commerce platforms. Online retailing enables vendors to reach a broader customer base, including home healthcare users, while minimizing setup, distribution, and operational costs. Customers benefit from the convenience of purchasing authentic products with manufacturer warranties, a wide range of options, and the availability of promotional offers. The COVID-19 pandemic further accelerated the demand for wearable fingertip pulse oximeters, leading to a surge in online sales and revenue growth in the global pulse oximetry market. As a result, the adoption of online marketing strategies by vendors is expected to fuel the market’s growth during the forecast period. 

The Pulse Oximetry market is experiencing significant growth due to increasing demand for patient monitoring devices, particularly among the geriatric population and those with respiratory disorders. Wireless pulse oximeters, such as Bluetooth devices, are trending due to their repositional flexibility and convenience. Oxygen saturation level monitoring is crucial for morbidity and mortality reduction in critical care, anesthesia, childbirth, surgery, neonatal, and pediatric care. Technological advancements include smart meters, alarm systems, and Bluetooth connectivity for proactive monitoring and remote patient care. Accuracy is key, with silicon adhesive and signal acquisition improving performance. Home consumers, clinicians, pilots, athletes, and mountaineers all benefit from pulse oximetry’s vital stats monitoring capabilities. The coronavirus pandemic has further boosted demand for home care and telehealth solutions. Memory and data transfer features enhance usability in hospitals and ambulatory surgical centers. 

Discover 360° analysis of this market. For complete information, schedule your consultation- Book Here!

Market Challenges

Pulse oximetry, a non-invasive method used to measure oxygen saturation levels in the blood, has become a standard tool in healthcare settings. However, it’s important to acknowledge the limitations and potential inaccuracies associated with this technology. Factors such as abnormal hemoglobin, anemia, reduced peripheral circulation, venous congestion, bright ambient light, and nail varnish can impact the accuracy of pulse oximeter readings. Additionally, some lower-priced pulse oximeters in the market have been found to provide inaccurate saturation readings during hypoxia and do not meet clinical standards. Conventional pulse oximetry technology also faces challenges, including difficulty in measuring oxygen saturation in the presence of motion artifacts or low perfusion, and failure to provide accurate measurements in the operating room. These limitations and potential inaccuracies may deter end-users from adopting pulse oximetry, negatively impacting the growth of the global pulse oximetry market.The Pulse Oximetry market faces several challenges in various sectors. In healthcare, ensuring patient safety during anesthesia, critical care, childbirth, and surgery is paramount. Pulse oximetry plays a crucial role in monitoring oxygen saturation levels. Technological advancements have led to the development of wrist, fingertip, and handheld pulse oximeters for proactive monitoring in home care and remote settings. The coronavirus pandemic has increased demand for these devices among home consumers and clinicians. In infants and neonates, accuracy is vital for newborn screening and pneumonia diagnosis. For pilots, athletes, and mountaineers, pulse oximeters ensure optimal performance. Challenges include ensuring accuracy, memory, data transfer via Bluetooth, and use in hospitals and ambulatory surgical centers.

For more insights on driver and challenges – Download a Sample Report

Segment Overview 

This pulse oximetry market report extensively covers market segmentation by

Product 1.1 Bedside/desktop pulse oximeters1.2 Handheld pulse oximeters1.3 Fingertip pulse oximeters1.4 Wrist-worn pulse oximetersEnd-user 2.1 Hospitals and clinics2.2 Alternative care settingsGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Bedside/desktop pulse oximeters-  Handheld pulse oximeters are essential medical devices with a user-friendly interface, connecting a probe assembly to a control unit. These devices offer various applications, from occasional spot checks to long-term monitoring of neonatal and adult patients in hospitals and homes. The handheld segment holds the second-largest share in the global pulse oximetry market. These devices feature larger displays, alarm limits, rechargeable batteries, and data transfer options via USB or IR. Widely used in hospitals, clinics, nursing homes, and operating theaters, handheld pulse oximeters are also adopted by individuals with chronic pulmonary conditions, athletes, firefighters, and pilots for continuous SpO2 level monitoring. Factors like ease of use, portability, and real-time monitoring drive market growth.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017 – 2021)  – Download a Sample Report

Learn and explore more about Technavio’s in-depth research reports

The global respiratory monitoring devices market is driven by increasing respiratory diseases worldwide, fostering demand for advanced diagnostic tools. Meanwhile, the global wearable medical devices market is expanding rapidly, propelled by advancements in sensor technology and growing health awareness. In parallel, the global pressure monitoring devices market is witnessing robust growth due to rising incidences of hypertension and cardiovascular diseases, prompting innovations in non-invasive monitoring solutions. These markets are poised for continued expansion, driven by technological advancements and the imperative for personalized healthcare solutions.

Research Analysis

The Pulse Oximetry market encompasses a range of patient monitoring devices used to measure oxygen saturation levels in the blood. These devices are essential for various applications, including geriatric population, respiratory disorders, anesthesia, critical care, childbirth, surgery, neonatal, and pediatric care. Technological advancements have led to the development of wireless Bluetooth and fingertip pulse oximeters, enabling remote monitoring and proactive intervention. Morbidity and mortality in these patient groups can be significantly reduced through effective oxygen saturation monitoring. Home consumers and clinicians alike benefit from these devices, with applications ranging from vital stats monitoring during coronavirus recovery to ongoing care for chronic conditions. The market continues to grow, driven by increasing demand for home care, patient safety, and the expanding use of pulse oximetry in diverse settings.

Market Research Overview

The Pulse Oximetry Market encompasses a range of patient monitoring devices used to measure oxygen saturation levels in the blood. These devices are essential in various healthcare settings, including geriatric care, critical care, anesthesia, surgery, pediatric care, and newborn screening. Pulse oximetry is particularly crucial for individuals with respiratory disorders, such as pneumonia, and those undergoing procedures that require close monitoring of vital stats. Technological advancements have led to the development of various types of pulse oximeters, including wireless and Bluetooth devices, which offer greater repositionability and convenience. Silicon adhesive and signal acquisition technologies ensure accurate readings, while smart meters and alarm systems provide real-time monitoring and patient safety. Pulse oximetry is also gaining popularity among home consumers, enabling proactive monitoring and remote care for individuals with chronic conditions. The market includes various types of pulse oximeters, such as wrist, fingertip, and handheld devices, catering to diverse user needs. The coronavirus pandemic has further accelerated the demand for pulse oximetry devices, as they enable early detection and monitoring of respiratory issues. Pulse oximetry plays a crucial role in patient safety, particularly in hospitals, ambulatory surgical centers, and during childbirth. It is also used by pilots, athletes, mountaineers, and infants, highlighting its broad applicability and importance in various sectors. Data transfer and memory features in pulse oximeters enable easy sharing of vital information between clinicians and healthcare providers, enhancing overall care quality.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ProductBedside/desktop Pulse OximetersHandheld Pulse OximetersFingertip Pulse OximetersWrist-worn Pulse OximetersEnd-userHospitals And ClinicsAlternative Care SettingsGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/pulse-oximetry-market-size-is-set-to-grow-by-usd-1-18-billion-from-2024-2028–increasing-prevalence-of-chronic-respiratory-diseases-to-boost-the-market-growth-technavio-302200568.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Global AI Leader and Enterprise Transformation Visionary Zeya Ottomone Appointed Chief Executive Officer of Integrow

Published

on

By

Author of Empowered to Execute in the Agentic Era to Lead Next Generation of AI-Powered Enterprise Innovation

ATLANTA, July 24, 2026 /PRNewswire-PRWeb/ — Integrow announced the appointment of Zeya Ottomone as Chief Executive Officer, marking a significant milestone in the company’s evolution as it accelerates its vision to become a global leader in Agentic AI-powered enterprise software and business transformation.

Integrow announced the appointment of Zeya Ottomone as Chief Executive Officer, marking a significant milestone in the company’s evolution as it accelerates its vision to become a global leader in Agentic AI-powered enterprise software and business transformation.

With more than three decades of executive leadership spanning Fortune 500 enterprises, global technology organizations, and enterprise software innovation, Ottomone joins Integrow at a defining moment in the evolution of artificial intelligence.

Widely recognized for helping organizations modernize operations, simplify complex business ecosystems, and deliver measurable transformation outcomes, Ottomone has led some of the industry’s largest enterprise modernization initiatives across ERP, CRM, workforce management, cloud computing, cybersecurity, artificial intelligence, and intelligent automation. His appointment signals Integrow’s commitment to redefining how enterprises execute strategy in the era of autonomous AI.

“Artificial Intelligence is no longer about automation alone, it’s about empowering organizations to execute faster, make smarter decisions, and fundamentally rethink how work gets done,” said Zeya Ottomone, Chief Executive Officer of Integrow. “We’re entering the Agentic Era, where intelligent AI agents become trusted digital teammates capable of planning, reasoning, collaborating and executing alongside people. At Integrow, we’re building the enterprise platform that makes that future practical, secure and measurable for every organization.”

Ottomone is internationally recognized as a leader in enterprise technology, SaaS transformation, digital modernization and AI-enabled business strategy. Throughout his career he has held executive leadership and C-level positions with ABB, Honeywell, AmerisourceBergen, Cable & Wireless, Chicago Tribune and Rimini Street, leading global organizations through large-scale transformation initiatives across North America, Europe, Asia-Pacific and the Middle East. His expertise spans enterprise applications, Salesforce ecosystems, ServiceNow, ERP modernization, customer experience, intelligent operations, data strategy, and the emerging field of Agentic AI.

Before joining Integrow, Ottomone led global SaaS Centers of Excellence focused on enterprise transformation, helping organizations modernize critical business operations while reducing technology complexity and accelerating innovation. A certified Lean Six Sigma Master Black Belt and recognized executive advisor, Ottomone has consistently delivered operational excellence by combining strategic leadership with emerging technologies to create sustainable business value.

His appointment also coincides with the upcoming publication of his new book, Empowered to Execute in the Agentic Era, which explores how organizations can bridge the gap between strategy and execution by leveraging AI, empowering people, and building intelligent enterprises capable of continuous innovation. The book reflects many of the same principles that will guide Integrow’s next phase of growth: human-centered AI, intelligent automation, operational excellence, and measurable business outcomes.

Under Ottomone’s leadership, Integrow will accelerate investment across:

Agentic AIEnterprise AI PlatformsIntelligent ERPAI-powered CRMHuman Capital ManagementIT Service ManagementPredictive AnalyticsAutonomous WorkflowsEnterprise CopilotsIndustry-specific AI Solutions

The company’s vision is to deliver a unified enterprise platform where AI is embedded into every business process, enabling organizations to eliminate operational silos, automate decision-making, increase productivity, and create competitive advantage through intelligent execution. “Zeya represents exactly the type of visionary leader required for the next generation of enterprise software,” said Harvey Nicholson, Chair of Corporate Governance and Member of Integrow’s Board of Directors. “His global experience, deep understanding of enterprise technology, and forward-looking vision for Agentic AI position Integrow to become one of the industry’s most innovative AI-powered enterprise software companies.”

Wayne Gadson, Chair of Growth Strategy, added: “The future belongs to organizations that can execute strategy with intelligence, speed and confidence. Zeya has spent his career helping enterprises achieve exactly that. His appointment marks the beginning of an exciting new chapter for Integrow, our customers and our partners worldwide.” As enterprises face mounting pressure to modernize operations, reduce costs, improve workforce productivity and harness the power of artificial intelligence, Integrow is uniquely positioned to help organizations transform through a single AI-powered enterprise platform that unifies finance, operations, customer engagement, workforce management, projects and service delivery.

“Our mission is simple,” Ottomone concluded. “We don’t believe AI should replace people. We believe AI should elevate people. The organizations that will define the next decade won’t simply adopt AI—they’ll empower every employee to execute better decisions every day. That’s the future Integrow is building.”

About Integrow

Integrow is a global enterprise software company delivering next-generation AI-powered business applications built on Salesforce. The platform unifies ERP, CRM, Human Capital Management, IT Service Management, Project Management, Field Service, Finance and Operations into a single intelligent ecosystem enhanced by Agentic AI.

By embedding artificial intelligence into every workflow, Integrow enables organizations to modernize operations, accelerate innovation, improve decision-making and execute strategy with confidence.

For more information, visit www.integrow.com.

Media Contact

Media Team, Integrow, Inc., 1 855-333-4769, info@integrow.com, www.integrow.com 

View original content to download multimedia:https://www.prweb.com/releases/global-ai-leader-and-enterprise-transformation-visionary-zeya-ottomone-appointed-chief-executive-officer-of-integrow-302833033.html

SOURCE Integrow, Inc.

Continue Reading

Technology

Lufax Announces Board and Management Changes

Published

on

By

SHANGHAI, July 24, 2026 /PRNewswire/ — Lufax Holding Ltd (“Lufax” or the “Company”) (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced changes to its board of directors and senior management, effective July 25, 2026.

Ms. Fangfang Cai (“Ms. Cai”), Mr. Shibang Guo (“Mr. Guo”) and Mr. Peifeng Li (“Mr. Li”) have resigned as non-executive directors of the Company and from their respective positions on the Board’s committees. Mr. Tongzhuan Xi (“Mr. Xi”) has resigned as an executive director, the chief financial officer and the authorised representative of the Company (“Authorised Representative”) under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (“Hong Kong Listing Rules”), with effect from July 25, 2026. Each of the four directors cited personal work arrangements as the reason for their resignation and confirmed there is no disagreement with the Board and no matter relating to their departure that needs to be brought to shareholders’ attention.

The Company has begun a search for a new chief financial officer. During the transition, the CFO’s duties will be temporarily assumed by the Company’s internal team to ensure continuity of the Company’s financial functions. Mr. Xiang Ji, an executive director and the Company’s chief executive officer, has been appointed as the Authorised Representative, the Company’s designated liaison with the Stock Exchange under the Hong Kong Listing Rules, in place of Mr. Xi, with effect from July 25, 2026.

The Board has appointed Mr. Wai Kin Chim (“Mr. Chim”) as an independent non-executive director for an initial three-year term commencing July 25, 2026.

Mr. Chim, aged 65, has over 40 years of experience in international banking and extensive board experience in Asia Pacific, having worked in Hong Kong, Singapore and Beijing. He specializes in risk management and internal control, with a strong emphasis on corporate governance, credit risk, market risk and capital management.

Mr. Chim served as a loan officer at Standard Chartered Bank, Hong Kong Branch, from October 1985 to August 1988. He was then employed by Bankers Trust Company, Hong Kong Branch, as a vice president of the Asia Credit Department from September 1988 to October 1996. He subsequently served as the managing director and the chief credit officer for Deutsche Bank AG, a company listed on the Frankfurt Stock Exchange under ticker symbol DBK, for Asia Pacific (non-Japan Asia), from October 1996 to November 2006. He joined Bank of China Limited, a company listed on the Main Board of the Stock Exchange under stock code 3988, as the chief credit officer from March 2007 to March 2015.

Mr. Chim was an independent non-executive director of Standard Chartered Bank (China) Limited from October 2015 to October 2017. He served as an independent non-executive director of HDR Global Trading Limited, owner and operator of the BitMEX digital asset trading platform, from February 2021 to February 2022. Mr. Chim served as a non-executive director of China Chengtong Hong Kong Company Limited from July 2022 to June 2025. Mr. Chim is currently an independent non-executive director of OCBC Bank (Hong Kong) Limited, since November 2017; an independent non-executive director of Banco OCBC (Macau), S.A., since August 2023; an independent non-executive director of China Intellogis Technology Co., Ltd., since June 2024; and a director of Hong Kong Dance Company Limited since June 2026.

Mr. Chim obtained a Bachelor of Science degree from the Chinese University of Hong Kong in 1983 and an MBA degree from Indiana State University, USA, in 1985. He also graduated from the Senior Executive Program at Columbia University in 2000.

In connection with these changes, with effect from July 25, 2026, Ms. Cai will step down from the Nomination and Remuneration Committee, and Mr. Koon Wing Ernest Ip has been appointed as a member to that committee. The Company’s Special Committee will comprise Mr. Dicky Peter Yip, Mr. Koon Wing Ernest Ip and Mr. Siu Hong Cheng, continuing under the chairmanship of Mr. Dicky Peter Yip, with effect from July 25, 2026.

The Board would like to take this opportunity to thank Ms. Cai, Mr. Guo, Mr. Li and Mr. Xi for their service during the tenure of their office and warmly welcome Mr. Chim to the Board.

About Lufax

Lufax is a leading financial services enabler for small business owners in China. The Company offers financing products designed principally to address the needs of small business owners. In doing so, the Company has established relationships with 85 financial institutions in China as funding partners, many of which have worked with the Company for over three years.

Investor Relations Contact

Lufax Holding Ltd
Email: Investor_Relations@lu.com

ICR, LLC
Robin Yang
Tel: +1 (646) 308-0546
Email: lufax.ir@icrinc.com

 

View original content:https://www.prnewswire.com/news-releases/lufax-announces-board-and-management-changes-302834065.html

SOURCE Lufax Holding Ltd

Continue Reading

Technology

UMD Smith School Researchers Warn AI Security Lapses Highlight Urgent Need for Independent Oversight

Published

on

By

COLLEGE PARK, Md., July 24, 2026 /PRNewswire/ — A series of recent AI security lapses—including the OpenAI–Hugging Face breach—raises a fundamental question, say a pair of researchers at the University of Maryland’s Robert H. Smith School of Business: Can tech companies safely govern the powerful AI systems they build, or is stronger outside oversight now essential?

In its incident report, OpenAI confirmed that one of its experimental AI agents exploited a weakness in its testing environment while working on a routine benchmark task. The system wasn’t instructed to behave maliciously; instead, its persistence turned a small design flaw into a real escape. Earlier tests showed similar behavior, including agents that learned to bypass security checks by manipulating authentication tokens.

This pattern echoes findings from Dean’s Professor of Information Systems Siva Viswanathan at the Smith School, who studies how large technology platforms enforce rules. His research on mobile app privacy—published in Management Science—examined Google’s rollout of Android 6.0, which gave users more control over what data apps could collect. Developers were granted a flexible window to update their apps. Many used that flexibility to delay compliance for months, continuing to gather user data until Google imposed consequences such as lower search rankings and reduced visibility in its app store.

Viswanathan’s takeaway: when companies rely on voluntary compliance, self‑interested actors often exploit the slack. Real accountability requires pairing flexibility with firm, enforceable penalties.

That lesson now reverberates across the AI sector. As companies race to build increasingly capable systems, Viswanathan says oversight must treat these AI systems as strategic actors and must include strong safeguards that can pause or reverse a system before harm occurs.

He notes that a separate study from Anthropic underscores the stakes. In controlled tests, even an AI system designed to monitor another AI inherited the same flaws it was supposed to catch. In some cases, the “judge” model failed to flag clear sabotage because it agreed with the agent’s goals, allowing dangerous behavior to pass without human review.

Balaji Padmanabhan, Dean’s Professor of Decisions, Operations and Information Technologies and director of the Smith School’s Center for Artificial Intelligence in Business, extends Viswanathan’s governance argument into the realm of autonomous AI agents, warning that the same structural weaknesses now carry far higher stakes.

“The fact that this breach occurred organically without the AI agent being asked to be malicious is itself notable. Imagine what someone who actually intends to do harm can do. It’s also not terribly reassuring that the same firms we depend on for AI infrastructure, who are facing these issues, are the ones assuring enterprises that their systems with guardrails are perfectly safe,” says Padmanabhan. “We have to wake up to the fact that we’ve created capabilities that let software become as powerful as we want it to be—and then some. It’s time we seriously ask what’s needed to create an infrastructure to play defense well.”

Across the independent studies, the pattern is consistent, says Viswanathan: Voluntary compliance fails when the governed actor is more capable than the regulator. And AI systems cannot be governed by trust or good intentions alone. Oversight must be preventive, independent and capable of stopping harmful behavior before it spreads.

About the University of Maryland’s Robert H. Smith School of Business
The Robert H. Smith School of Business is an internationally recognized leader in management education and research. One of 12 colleges and schools at the University of Maryland, College Park, the Smith School offers undergraduate, full-time and flex MBA, executive MBA, online MBA, business master’s, PhD and executive education programs, as well as outreach services to the corporate community. The school offers its degree, custom and certification programs in learning locations in North America and Asia.

Contact: Greg Muraski, gmuraski@umd.edu

View original content:https://www.prnewswire.com/news-releases/umd-smith-school-researchers-warn-ai-security-lapses-highlight-urgent-need-for-independent-oversight-302834112.html

SOURCE University of Maryland’s Robert H. Smith School of Business

Continue Reading

Trending